AU2001272906B2 - Imidazopyridine and imidazopyrimidine antiviral agents - Google Patents

Imidazopyridine and imidazopyrimidine antiviral agents Download PDF

Info

Publication number
AU2001272906B2
AU2001272906B2 AU2001272906A AU2001272906A AU2001272906B2 AU 2001272906 B2 AU2001272906 B2 AU 2001272906B2 AU 2001272906 A AU2001272906 A AU 2001272906A AU 2001272906 A AU2001272906 A AU 2001272906A AU 2001272906 B2 AU2001272906 B2 AU 2001272906B2
Authority
AU
Australia
Prior art keywords
compound
mmol
nmr
pct
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2001272906A
Other languages
English (en)
Other versions
AU2001272906A1 (en
Inventor
Rita L. Civiello
Keith D. Combrink
Hatice Belgin Gulgeze
Nicholas A. Meanwell
Ny Sin
Brian Lee Venables
Xiangdong Wang
Kuo-Long Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2001272906A1 publication Critical patent/AU2001272906A1/en
Application granted granted Critical
Publication of AU2001272906B2 publication Critical patent/AU2001272906B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2001272906A 2000-06-13 2001-05-08 Imidazopyridine and imidazopyrimidine antiviral agents Ceased AU2001272906B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21144700P 2000-06-13 2000-06-13
US60/211,447 2000-06-13
US26336301P 2001-01-22 2001-01-22
US60/263,363 2001-01-22
PCT/US2001/014775 WO2001095910A1 (en) 2000-06-13 2001-05-08 Imidazopyridine and imidazopyrimidine antiviral agents

Publications (2)

Publication Number Publication Date
AU2001272906A1 AU2001272906A1 (en) 2002-03-14
AU2001272906B2 true AU2001272906B2 (en) 2004-08-26

Family

ID=26906145

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001272906A Ceased AU2001272906B2 (en) 2000-06-13 2001-05-08 Imidazopyridine and imidazopyrimidine antiviral agents
AU7290601A Pending AU7290601A (en) 2000-06-13 2001-05-08 Imidazopyridine and imidazopyrimidine antiviral agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU7290601A Pending AU7290601A (en) 2000-06-13 2001-05-08 Imidazopyridine and imidazopyrimidine antiviral agents

Country Status (20)

Country Link
US (1) US6489338B2 (cg-RX-API-DMAC7.html)
EP (1) EP1311268A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004503501A (cg-RX-API-DMAC7.html)
KR (1) KR20030008151A (cg-RX-API-DMAC7.html)
CN (1) CN1436079A (cg-RX-API-DMAC7.html)
AR (1) AR029128A1 (cg-RX-API-DMAC7.html)
AU (2) AU2001272906B2 (cg-RX-API-DMAC7.html)
BR (1) BR0111569A (cg-RX-API-DMAC7.html)
CA (1) CA2412327A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20024078A3 (cg-RX-API-DMAC7.html)
HU (1) HUP0400766A2 (cg-RX-API-DMAC7.html)
IL (1) IL152889A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02012204A (cg-RX-API-DMAC7.html)
NO (1) NO20025977L (cg-RX-API-DMAC7.html)
NZ (1) NZ523566A (cg-RX-API-DMAC7.html)
PE (1) PE20011348A1 (cg-RX-API-DMAC7.html)
PL (1) PL360290A1 (cg-RX-API-DMAC7.html)
RU (1) RU2003100828A (cg-RX-API-DMAC7.html)
UY (1) UY26758A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001095910A1 (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774134B2 (en) * 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
JP2005511714A (ja) * 2001-12-10 2005-04-28 ブリストル−マイヤーズ スクイブ カンパニー Rsv融合インヒビターのジ塩酸塩・モノ水和物
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
WO2004043913A2 (en) * 2002-11-08 2004-05-27 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof
JP2007501252A (ja) * 2003-08-05 2007-01-25 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答調整剤を含有する製剤
EP1682547B1 (en) 2003-10-30 2012-10-24 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
CN100582109C (zh) 2003-12-24 2010-01-20 生物区科学管理控股有限公司 用于治疗呼吸道合胞体病毒感染的多环试剂
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
CA2574220C (en) 2004-07-27 2014-09-16 Gilead Sciences, Inc. Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
CA2612263C (en) 2005-06-20 2015-04-14 Tibotec Pharmaceuticals Ltd. 1-(2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl)-3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
BRPI0611744B8 (pt) 2005-06-20 2021-05-25 Janssen R & D Ireland benzimidazóis heterociclilaminoalquila substituída, seu processo de preparação e composição farmacêutica
JP5070207B2 (ja) 2005-06-20 2012-11-07 テイボテク・フアーマシユーチカルズ 2−置換ベンズイミダゾール
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
WO2009084544A1 (ja) * 2007-12-27 2009-07-09 Idemitsu Kosan Co., Ltd. 含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
WO2010103306A1 (en) 2009-03-10 2010-09-16 Astrazeneca Uk Limited Benzimidazole derivatives and their use as antivaral agents
RU2407738C1 (ru) * 2009-07-03 2010-12-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Противовирусный активный компонент, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
WO2011115150A1 (ja) * 2010-03-18 2011-09-22 興和株式会社 ベンゾチアジン化合物の製造方法
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
TWI541241B (zh) * 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI515187B (zh) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI501967B (zh) * 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
CN103860538B (zh) * 2011-03-23 2016-03-02 上海市第一人民医院 靶向人La蛋白的先导化合物及其在制备抗乙型肝炎病毒的药物中的用途
EA028626B1 (ru) * 2012-06-11 2017-12-29 Юсб Байофарма Спрл БЕНЗИМИДАЗОЛЫ, МОДУЛИРУЮЩИЕ TNF-α
CN104470916A (zh) * 2012-06-15 2015-03-25 爱尔兰詹森研发公司 新颖的作为呼吸道合胞病毒抗病毒剂的被苯并咪唑取代的1,3-二氢-2h-苯并咪唑-2-酮衍生物
AU2013276519B2 (en) * 2012-06-15 2017-05-25 Janssen Sciences Ireland Uc 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
KR20150032283A (ko) * 2012-06-15 2015-03-25 얀센 알 앤드 디 아일랜드 호흡기 합포체 바이러스의 항바이러스제로서의 헤테로사이클로 치환된 1,3-디하이드로-2h-벤즈이미다졸-2-온 유도체
JP2015519385A (ja) * 2012-06-15 2015-07-09 ヤンセン・アールアンドデイ・アイルランド Rsウイルス抗ウイルス薬としての、ベンゾイミダゾールによって置換された新規4−置換1,3−ジヒドロ−2h−ベンゾイミダゾル−2−オン誘導体
DK2909195T3 (en) * 2012-10-16 2017-09-25 Janssen Sciences Ireland Uc ANTIVIRAL RELATIONS TO RSV
JP2016145155A (ja) * 2013-04-30 2016-08-12 日本農薬株式会社 フタルアミド誘導体及び該誘導体を含有する農園芸用殺虫剤並びにその使用方法
KR20160075766A (ko) * 2013-10-29 2016-06-29 메디비르 아베 퀴나졸린계 호흡기 세포융합 바이러스 억제제
WO2015065336A1 (en) * 2013-10-29 2015-05-07 Medivir Ab Respiratory syncytial virus inhibitors
WO2017066014A1 (en) * 2015-10-14 2017-04-20 Sunnylife Pharma Inc. Bruton's tyrosine kinase inhibitors
WO2019046364A1 (en) * 2017-08-29 2019-03-07 Emory University INHIBITORS OF SYNCYTIAL RESPIRATORY VIRUS (RSV) REPLICATION AND USES THEREOF
PH12022551042A1 (en) * 2019-10-30 2023-05-29 Janssen Sciences Ireland Unlimited Co Synthesis of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2 yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one
KR20220097385A (ko) * 2019-10-30 2022-07-07 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 3-니트로-n-(2,2,2-트리플루오로에틸)-4-피리딘아민의 합성
WO2021250180A1 (en) 2020-06-11 2021-12-16 Janssen Sciences Ireland Unlimited Company Hemi (l)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2 yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one and pharmaceutical compositions comprising the same
WO2022184606A1 (en) * 2021-03-01 2022-09-09 Janssen Sciences Ireland Unlimited Company Synthesis of rilematovir
MX2024009216A (es) * 2022-01-28 2024-08-06 Insilico Medicine Ip Ltd Inhibidores de ectonucleotido pirofosfatasa-fosfodiesterasa 1 (enpp1) y usos de los mismos.
WO2025026383A1 (en) * 2023-08-02 2025-02-06 Insilico Medicine Ip Limited Crytsalline forms of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US5256668A (en) 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
CA2197393A1 (en) 1996-02-13 1997-08-14 Yakov Gluzman (Deceased) Triazine containing anionic compounds useful as antiviral agents
JP2002501894A (ja) 1998-01-29 2002-01-22 バイロファーマ・インコーポレイテッド ニューモウイルス感染および関連疾患の治療または予防のための化合物、組成物および方法
CA2338147A1 (en) 1998-07-20 2000-02-03 Kuo-Long Yu Substituted benzimidazole antiviral agents
HRP20080390A2 (en) 1999-06-28 2008-12-31 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds

Also Published As

Publication number Publication date
US6489338B2 (en) 2002-12-03
NO20025977L (no) 2003-01-29
NO20025977D0 (no) 2002-12-12
KR20030008151A (ko) 2003-01-24
EP1311268A4 (en) 2004-06-30
WO2001095910A1 (en) 2001-12-20
UY26758A1 (es) 2002-01-31
NZ523566A (en) 2004-08-27
PL360290A1 (en) 2004-09-06
BR0111569A (pt) 2003-04-29
IL152889A0 (en) 2003-06-24
MXPA02012204A (es) 2003-10-15
US20020016309A1 (en) 2002-02-07
CN1436079A (zh) 2003-08-13
HUP0400766A2 (hu) 2004-07-28
AR029128A1 (es) 2003-06-04
RU2003100828A (ru) 2004-06-27
CZ20024078A3 (cs) 2003-08-13
AU7290601A (en) 2001-12-24
EP1311268A1 (en) 2003-05-21
PE20011348A1 (es) 2002-02-07
JP2004503501A (ja) 2004-02-05
CA2412327A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
AU2001272906B2 (en) Imidazopyridine and imidazopyrimidine antiviral agents
AU2001272906A1 (en) Imidazopyridine and imidazopyrimidine antiviral agents
CN101351466B (zh) Janus激酶3的杂环抑制剂
TWI804003B (zh) Tlr7/8拮抗劑及其用途
EP1852434B1 (en) Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
US6506738B1 (en) Benzimidazolone antiviral agents
JP5287253B2 (ja) 縮合ピリジン化合物
AU2019416589A1 (en) Heterocyclic compound intermediate, preparation method therefor and application thereof
EP3833671B1 (en) Substituted thienopyrroles as pad4 inhibitors
CA2872110C (en) Nitrogenous heterocyclic derivatives and their application in drugs
AU2003223627B2 (en) (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
CA2509711A1 (en) Piperidine derivatives as ccr5 antagonists
JP2009522232A (ja) Pdfインヒビター
AU2013341185A1 (en) Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNalpha responses
AU2003243709A1 (en) Indole derivatives useful as histamine h3 antagonists
JP2004520387A (ja) 複素環式置換2−メチル−ベンズイミダゾール抗ウイルス剤
AU2003223631A1 (en) 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
JPH0881466A (ja) イミダゾピリジン化合物
CA3108871A1 (en) Substituted benzimidazoles as pad4 inhibitors
EP4277982A1 (en) Macrocycle complement factor b inhibitors
WO2018015818A2 (en) Therapeutic inhibitory compounds
CA3176142A1 (en) Phd inhibitor compounds, compositions, and use
ZA200210104B (en) Imidazopyridine and imidazopyrimidine antiviral agents.
TW202508569A (zh) 做為ripk1抑制劑的異㗁唑烷類及其用途(一)
HK1123303B (en) Heterocyclic janus kinase 3 inhibitors

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired